Invention Grant
- Patent Title: Use of cannabidiol in the treatment of epilepsy
-
Application No.: US15519233Application Date: 2015-10-14
-
Publication No.: US10765643B2Publication Date: 2020-09-08
- Inventor: Geoffrey Guy , Stephen Wright , Orrin Devinsky
- Applicant: GW Pharma Limited
- Applicant Address: GB Cambridge
- Assignee: GW Research Limited
- Current Assignee: GW Research Limited
- Current Assignee Address: GB Cambridge
- Agency: Cooley LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@129bb4d4
- International Application: PCT/GB2015/053029 WO 20151014
- International Announcement: WO2016/059404 WO 20160421
- Main IPC: A61K31/05
- IPC: A61K31/05 ; A61K36/185 ; A61K45/06 ; A61K31/352 ; A61K9/08 ; A61K47/10 ; A61K47/26 ; A61K47/44
Abstract:
The present disclosure relates to the use of cannabidiol (CBD) for the treatment of seizures associated with Aicardi Syndrome. In one embodiment the seizures associated with Aicardi Syndrome are convulsive seizures; focal seizures with impairment or infantile spasm. The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs).
Public/Granted literature
- US20170231923A1 USE OF CANNABIDIOL IN THE TREATMENT OF EPILEPSY Public/Granted day:2017-08-17
Information query
